SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
View ORCID ProfileSaki Takahashi, View ORCID ProfileMichael J. Peluso, Jill Hakim, Keirstinne Turcios, Owen Janson, View ORCID ProfileIsobel Routledge, Michael P. Busch, Rebecca Hoh, Viva Tai, J. Daniel Kelly, View ORCID ProfileJeffrey N. Martin, View ORCID ProfileSteven G. Deeks, View ORCID ProfileTimothy J. Henrich, View ORCID ProfileBryan Greenhouse, View ORCID ProfileIsabel Rodríguez-Barraquer
doi: https://doi.org/10.1101/2021.09.09.21263139
Saki Takahashi
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Michael J. Peluso
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Jill Hakim
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Keirstinne Turcios
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Owen Janson
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Isobel Routledge
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Michael P. Busch
2Department of Laboratory Medicine, University of California, San Francisco, USA
3Vitalant Research Institute, San Francisco, USA
Rebecca Hoh
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Viva Tai
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
J. Daniel Kelly
4Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
5Institute for Global Health Sciences, University of California, San Francisco, USA
6F.I. Proctor Foundation, University of California, San Francisco, USA
Jeffrey N. Martin
4Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
Steven G. Deeks
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Timothy J. Henrich
7Division of Experimental Medicine, University of California, San Francisco, USA
Bryan Greenhouse
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Isabel Rodríguez-Barraquer
1Division of HIV, Infectious Diseases & Global Medicine, University of California, San Francisco, USA
Data Availability
Raw antibody data used in this analysis are publicly available in a prior publication (17). Raw serosurvey data are available in the citations in Table 1. Access to COVID-19 seroprevalence data from the Nationwide Commercial Laboratory Seroprevalence Survey is maintained by the Centers for Disease Control and Prevention's (CDC)'s Epi Task Force Seroprevalence Team. Requests for access to the data should be directed to: eocevent452@cdc.gov. The CDC does not take responsibility for the scientific validity or accuracy of methodology, results, statistical analyses, or conclusions presented.
Posted September 14, 2021.
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
Saki Takahashi, Michael J. Peluso, Jill Hakim, Keirstinne Turcios, Owen Janson, Isobel Routledge, Michael P. Busch, Rebecca Hoh, Viva Tai, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Bryan Greenhouse, Isabel Rodríguez-Barraquer
medRxiv 2021.09.09.21263139; doi: https://doi.org/10.1101/2021.09.09.21263139
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
Saki Takahashi, Michael J. Peluso, Jill Hakim, Keirstinne Turcios, Owen Janson, Isobel Routledge, Michael P. Busch, Rebecca Hoh, Viva Tai, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Bryan Greenhouse, Isabel Rodríguez-Barraquer
medRxiv 2021.09.09.21263139; doi: https://doi.org/10.1101/2021.09.09.21263139
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2811)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12502)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4366)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2814)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6724)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)